Haemonetics (HAE) reported $345.51 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 8.6%. EPS of $1.12 for the same period compares to $0.99 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $343.02 million, representing a surprise of +0.73%. The company delivered an EPS surprise of +2.75%, with the consensus EPS estimate being $1.09.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wal ...